Clinical Trials Browser

Phase 4 × Polycystic Ovary Syndrome × Sitagliptin Phosphate × Clear all

NCT02122380 2020-05-08

The Effect of Dipeptidyl Peptidase 4 Inhibition on Growth Hormone Secretion in Women With Polycystic Ovarian Syndrome

Phase 4 Completed

23 enrolled 12 charts

Polycystic Ovary Syndrome

NCT02941445 2016-10-21

Weight Maintenance With Dipeptidyl Peptidase 4 (DPP4) Inhibitor Sitagliptin in Combination With Metformin After Liragludite Induced Weight Loss

Phase 4 Completed

Body Weight, Polycystic Ovary Syndrome